- Global Pharma News & Resources

Oncology Biomarker Market Size & Share set for accelerated growth by 2027

Oncology Biomarker Market Size & Share set for accelerated growth by 2027


Latest Oncology Biomarker Market report published by Value Market Research provides a detailed market analysis comprising of market size, share, value, growth and trends for the period 2020-2027. The report encompasses data regarding market share and recent developments by key players. Moreover, this market report also covers regional and country market in detail.
Editor: Akshay N Last Updated: 03-Feb-2021

The global Oncology Biomarker Market research report, recently added by Value Market Research, is entailed of various market parameters including market outlook, share, trends, growth, value and factors that are currently influencing the market dynamics. The report discloses forecast for the period 2020-2027 based on the historical data. Additionally, this report also maps the recent strategic developments of key players along with their market share.

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the oncology biomarker market include Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, F.Hoffmann-La Roche Ltd., Genomic Health, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Pfizer, Inc. and Qiagen N.V. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

Get more information on "Global Oncology Biomarker Market Research Report" by requesting FREE Sample Copy at

Market Dynamics

Growing count of the population suffering from various types of cancer has created demand of biomarkers leading to early diagnosis and prognosis of cancer. Increase funding by government for cancer diagnosis technique and treatment is fueling the market growth. Owing to a non-invasive method for cancer detection followed by increased cancer awareness is boosting the market growth. In spite of this advantage, high cost associated with diagnosis is restraining the market growth.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of oncology biomarker.

Browse Global Oncology Biomarker Market Research Report with detailed TOC at

Market Segmentation

The broad oncology biomarker market has been sub-grouped into profiling technology, biomolecule, cancer type, and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Profiling Technology

  1. Omics Technology
  • Genomics
  • Proteomics
  • Other Omics Technologies
  1. Imaging Technology
  2. Immunoassays
  3. Cytogenetic-Based Tests

By Biomolecule

  • Genetic Biomarkers
  • Protein Biomarkers
  • Glycol-Biomarkers

By Cancer Type

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Others

By Application

  • Diagnostics
  • Drug Discovery And Development
  • Prognostics
  • Risk Assessment
  • Others

Regional Analysis

Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for oncology biomarker in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Purchase complete Global Oncology Biomarker Market Research Report at

About Us:

Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.

We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.


Value Market Research

401/402, TFM, Nagras Road, Aundh, Pune-7.

Maharashtra, INDIA.

Tel: +1-888-294-1147